|
1
|
Hansen MF: Genetic and molecular aspects
of osteosarcoma. J Musculoskelet Neuronal Interact. 2:554–560.
2002.PubMed/NCBI
|
|
2
|
Hayden JB and Hoang BH: Osteosarcoma:
Basic science and clinical implications. Orthop Clin North Am.
37:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Link MP, Goorin AM, Miser AW, Green AA,
Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick
JA, et al: The effect of adjuvant chemotherapy on relapse-free
survival in patients with osteosarcoma of the extremity. N Engl J
Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodriguez NI, Hoots WK, Koshkina NV,
Morales-Arias JA, Arndt CA, Inwards CY, Hawkins DS, Munsell MF and
Kleinerman ES: COX-2 expression correlates with survival in
patients with osteosarcoma lung metastases. J Pediatr Hematol
Oncol. 30:507–512. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang CJ, Yang D and Luo YW: Recombinant
ING4 suppresses the migration of SW579 thyroid cancer cells via
epithelial to mesenchymal transition. Exp Ther Med. 10:603–607.
2015.PubMed/NCBI
|
|
7
|
Zhang H, Zhou X, Xu C, Yang J, Xiang J,
Tao M and Xie Y: Synergistic tumor suppression by
adenovirus-mediated ING4/PTEN double gene therapy for gastric
cancer. Cancer Gene Ther. 23:13–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan A, Yang C, Chen Z, Li C and Cai L:
miR-761 promotes progression and metastasis of non-small cell lung
cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 37:55–66.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J, Zhu Y, Xu C, Xu H, Zhou X, Yang J,
Xie Y and Tao M: Adenovirus-mediated p53 and ING4 gene co-transfer
elicits synergistic antitumor effects through enhancement of p53
acetylation in breast cancer. Oncol Rep. 35:243–522.
2016.PubMed/NCBI
|
|
10
|
Garkavtsev I, Kozin SV, Chernova O, Xu L,
Winkler F, Brown E, Barnett GH and Jain RK: The candidate tumour
suppressor protein ING4 regulates brain tumour growth and
angiogenesis. Nature. 428:328–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klironomos G, Bravou V, Papachristou DJ,
Gatzounis G, Varakis J, Parassi E, Repanti M and Papadaki H: Loss
of inhibitor of growth (ING-4) is implicated in the pathogenesis
and progression of human astrocytomas. Brain Pathol. 20:490–497.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Zhang Q, Cai L, Wang Y, Wang Q,
Huang X, Fu S, Bai J, Liu J, Zhang G and Qi J: Inhibitor of growth
4 induces apoptosis in human lung adenocarcinoma cell line A549 via
Bcl-2 family proteins and mitochondria apoptosis pathway. J Cancer
Res Clin Oncol. 135:829–835. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Yu L, Wang Y, Zhang Y, Wang Y and
Zhang G: Expression of tumor suppressor gene ING4 in ovarian
carcinoma is correlated with microvessel density. J Cancer Res Clin
Oncol. 138:647–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nozell S, Laver T, Moseley D, Nowoslawski
L, De Vos M, Atkinson GP, Harrison K, Nabors LB and Benveniste EN:
The ING4 tumor suppressor attenuates NF-kappaB activity at the
promoters of target genes. Mol Cell Biol. 28:6632–6645. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie YF, Sheng W, Xiang J, Zhang H, Ye Z
and Yang J: Adenovirus-mediated ING4 expression suppresses
pancreatic carcinoma cell growth via induction of cell-cycle
alteration, apoptosis and inhibition of tumor angiogenesis. Cancer
Biother Radiopharm. 24:261–269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiseki M, Nagashima M, Pedeux RM,
Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y,
Appella E, Yokota J and Harris CC: p29ING4 and p28ING5 bind to p53
and p300 and enhance p53 activity. Cancer Res. 63:2373–2378.
2003.PubMed/NCBI
|
|
17
|
Zhang X, Xu LS, Wang ZQ, Wang KS, Li N,
Cheng ZH, Huang SZ, Wei DZ and Han ZG: ING4 induces G2/M cell cycle
arrest and enhances the chemosensitivity to DNA-damage agents in
HepG2 cells. FEBS Lett. 570:7–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z, Xie Y, Sheng W, Miao J, Xiang J and
Yang J: Tumor-suppressive effect of adenovirus-mediated inhibitor
of growth 4 gene transfer in breast carcinoma cells in vitro and in
vivo. Cancer Biother Radiopharm. 25:427–437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J and Li G: Cell cycle regulator ING4
is a suppressor of melanoma angiogenesis that is regulated by the
metastasis suppressor BRMS1. Cancer Res. 70:10445–10453. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai L, Li X, Zheng S, Wang Y, Wang Y, Li
H, Yang J and Sun J: Inhibitor of growth 4 is involved in
melanomagenesis and induces growth suppression and apoptosis in
melanoma cell line M14. Melanoma Res. 19:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Cai L, Chen H, Zhang Q, Zhang S,
Wang Y, Dong Y, Cheng H and Qi J: Inhibitor of growth 4 induces
growth suppression and apoptosis in glioma U87MG. Pathobiology.
76:181–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Cai L, Liang M, Wang Y, Yang J and
Zhao Y: ING4 induces cell growth inhibition in human lung
adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling
pathway. Anat Rec (Hoboken). 291:593–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hung T, Binda O, Champagne KS, Kuo AJ,
Johnson K, Chang HY, Simon MD, Kutateladze TG and Gozani O: ING4
mediates crosstalk between histone H3 K4 trimethylation and H3
acetylation to attenuate cellular transformation. Mol Cell.
33:248–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ozer A and Bruick RK: Regulation of HIF by
prolyl hydroxylases: Recruitment of the candidate tumor suppressor
protein ING4. Cell Cycle. 4:1153–1156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ozer A, Wu LC and Bruick RK: The candidate
tumor suppressor ING4 represses activation of the hypoxia inducible
factor (HIF). Proc Natl Acad Sci USA. 102:7481–7486. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim S, Chin K, Gray JW and Bishop JM: A
screen for genes that suppress loss of contact inhibition:
Identification of ING4 as a candidate tumor suppressor gene in
human cancer. Proc Natl Acad Sci USA. 101:16251–16256. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen JC, Unoki M, Ythier D, Duperray A,
Varticovski L, Kumamoto K, Pedeux R and Harris CC: Inhibitor of
growth 4 suppresses cell spreading and cell migration by
interacting with a novel binding partner, liprin alpha1. Cancer
Res. 67:2552–2558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang F, Luo LB, Tao YM, Wu F and Yang LY:
Decreased expression of inhibitor of growth 4 correlated with poor
prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers
Prev. 18:409–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Martinka M and Li G: Role of ING4 in
human melanoma cell migration, invasion and patient survival.
Carcinogenesis. 29:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li M, Jin Y, Sun WJ, Yu Y, Bai J, Tong DD,
Qi JP, Du JR, Geng JS, Huang Q, et al: Reduced expression and novel
splice variants of ING4 in human gastric adenocarcinoma. J Pathol.
219:87–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang QS, Li M, Zhang LY, Jin Y, Tong DD,
Yu Y, Bai J, Huang Q, Liu FL, Liu A, et al: Down-regulation of ING4
is associated with initiation and progression of lung cancer.
Histopathology. 57:271–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Borkosky SS, Gunduz M, Beder L, Tsujigiwa
H, Tamamura R, Gunduz E, Katase N, Rodriguez AP, Sasaki A, Nagai N
and Nagatsuka H: Allelic loss of the ING gene family loci is a
frequent event in ameloblastoma. Oncol Res. 18:509–518. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim S, Welm AL and Bishop JM: A dominant
mutant allele of the ING4 tumor suppressor found in human cancer
cells exacerbates MYC-initiated mouse mammary tumorigenesis. Cancer
Res. 70:5155–5162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mastroleo I: Post-trial obligations in the
Declaration of Helsinki 2013: Classification, reconstruction and
interpretation. Dev World Bioeth. Oct 19–2015.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 153:106–120. 1980.PubMed/NCBI
|
|
36
|
Enneking WF: A system of staging
musculoskeletal neoplasms. Clin Orthop Relat Res. 204:9–24.
1986.PubMed/NCBI
|
|
37
|
Mathema VB and Koh YS: Inhibitor of
growth-4 mediates chromatin modification and has a suppressive
effect on tumorigenesis and innate immunity. Tumour Biol. 33:1–7.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao ZL, He SB, Sheng WH, Dong XQ and Yang
JC: Adenovirus-mediated ING4 expression reduces multidrug
resistance of human gastric carcinoma cells in vitro and in vivo.
Oncol Rep. 30:2187–2194. 2013.PubMed/NCBI
|
|
39
|
Byron SA, Min E, Thal TS, Hostetter G,
Watanabe AT, Azorsa DO, Little TH, Tapia C and Kim S: Negative
regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
PLoS One. 7:e468232012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han Z, Zhou C, Sun B, Yan Q and Zhang J:
Experimental studies on the inhibition of adenovirus-ING4-OSM
therapy on nasopharyngeal carcinoma proliferation in vitro and in
vivo. Cell Biochem Biophys. 70:1573–1578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lou C, Jiang S, Guo X and Dong XS: ING4 is
negatively correlated with microvessel density in colon cancer.
Tumour Biol. 33:2357–2364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li S, Fan T, Liu H, Chen J, Qin C and Ren
X: Tumor suppressor ING4 overexpression contributes to
proliferation and invasion inhibition in gastric carcinoma by
suppressing the NF-κB signaling pathway. Mol Biol Rep.
40:5723–5732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei Q, He W, Lu Y, Yao J and Cao X: Effect
of the tumor suppressor gene ING4 on the proliferation of MCF-7
human breast cancer cells. Oncol Lett. 4:438–442. 2012.PubMed/NCBI
|
|
44
|
Xu M, Xie Y, Sheng W, Miao J and Yang J:
Adenovirus-mediated ING4 gene transfer in osteosarcoma suppresses
tumor growth via induction of apoptosis and inhibition of tumor
angiogenesis. Technol Cancer Res Treat. 14:369–378. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li M, Zhu Y, Zhang H, Li L, He P, Xia H,
Zhang Y and Mao C: Delivery of inhibitor of growth 4 (ING4) gene
significantly inhibits proliferation and invasion and promotes
apoptosis of human osteosarcoma cells. Sci Rep. 4:73802014.
View Article : Google Scholar : PubMed/NCBI
|
